Treatment of akinetic mutism with intramuscular olanzapine: A case series

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 20, Issue 1, 2008, Pages 93-95

  Spiegel, David R ^a   Casella, Daniel P ^a   Callender, David M ^a   Dhadwal, Neetu ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; OLANZAPINE;

ADULT; AGED; AKINETIC MUTISM; APATHY; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CINGULATE GYRUS; CLINICAL FEATURE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 39749142536     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.1.93     Document Type: Article

References (14)

1. Sadock BJ, Sadock VA: Comprehensive Textbook of Psychiatry, 7th ed. Philadelphia, Williams & Wilkins, 2000
2. Anderson CA, Arciniegas DB, Huddle DC, et al: Akinetic mutism following unilateral anterior cerebral artery occlusion. J Neuropsychiatry Clin Neurosci 2003; 15:385-386
3. Burruss JW, Chacko RC: Episodically remitting akinetic mutism following subarachnoid hemorrhage. J Neuropsychiatry Clin Neurosci 1999; 11:100-102
4. Trzepacz P, Meagher D: Delirium, in Textbook of Psychosomatic Medicine, 1st ed. Edited by Levenson JL. Arlington, VA, American Psychiatric Publishing, Inc., 2005, pp 91-130
5. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
6. Combarros O, Infante J, Berciano J: Akinetic mutism from frontal lobe damage responding to levodopa. J Neurol 2000; 247:568-569
7. Psarros T, Zouros A, Coimbra C: Bromocriptine-responsive akinetic mutism after endoscopy for ventricular neurocysticercosis: case report and review of the literature. J Neurosurg 2003; 99:397-401
8. Fink M, Taylor M: Catatonia: subtype or syndrome in DSM? Am J Psychiatry 2006; 163:1875-1876
9. Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43:175-182
10. Wright P, Birkett M, David SR, et al: Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 2001; 158:1149-1151
11. Lee KS, Bae WK, Bae HG, et al: The computed tomographic attenuation and the age of subdural hematomas. J Korean Med Sci 1997; 12:353-359
12. Volavka J, Czobor P, Sheitman B, et al: Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 2002; 159:255-262
13. Stahl SM: Describing an atypical antipsychotic receptor binding and its role in pathophysiology. Prim Care Companion J Clin Psychiatry 2003; 5:9-1
14. Steinlin M, Imfeld S, Zulauf P, et al. Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood. Brain 2003; 126:1998-2008